Results 181 to 190 of about 1,456,631 (242)
Frequency and Antimicrobial Susceptibility Patterns of Canine and Feline Urinary Tract Pathogens: A 6-Year (2018-2023) Retrospective Study in Phoenix, Arizona, United States. [PDF]
De Luca E +4 more
europepmc +1 more source
Real-world outcomes of cefepime/enmetazobactam for Enterobacterales infections: a retrospective descriptive study. [PDF]
Bonazzetti C +29 more
europepmc +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Beta-Lactamase Epidemiology and the Utility of Established and Novel Beta-Lactamase Inhibitors.
Expert Opinion on Investigational Drugs, 2000beta-Lactamase inhibitor:beta-lactam combinations remain one of the most successful strategies for the treatment of bacterial infections. Over the last 20 years the number and diversity of serine and metallo active site beta-lactamases has increased dramatically. This review highlights some of the new additions to the beta-lactamase arena and discusses
David J Payne, D J Payne
exaly +3 more sources
The use of successive generations of beta-lactams has selected successive generations of beta-lactamases including CTX-M ESBLs, AmpC beta-lactamases, and KPC carbapenamases in Enterobacteriaceae. Moreover, this cephalosporin resistance, along with rising
Haris M Khan, P M Hawkey, M Shahid
exaly +2 more sources
Beta-lactamase inhibitor combinations
Medical Clinics of North America, 1995The beta-lactamase inhibitor combinations present a novel approach to the problem of beta-lactamase-induced resistance to antibiotics. These agents are derived from the generally safe beta-lactam class of antibiotics. They are all principally excreted through the kidneys and require dosage adjustment in the face of significant renal insufficiency. They
J W, Sensakovic, L G, Smith
openaire +2 more sources

